Keyes Jason A
Chief Financial Officer
Keyes Jason A has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 10, 2026.
On the most recent filing, Keyes Jason A is listed as Chief Financial Officer at BlossomHill Therapeutics, Inc. Inside the rolling window, Keyes Jason A reported 1 open-market purchase totaling $11K in BLSM and no open-market sales.
Companies traded
Other insiders at BLSM
Insider Buying
$11K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Keyes Jason A made?
Keyes Jason A has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Keyes Jason A trade?
Keyes Jason A has filed SEC Form 4 disclosures for 1 company, including BLSM.
When was Keyes Jason A's most recent SEC Form 4 filing?
Keyes Jason A's most recent SEC Form 4 filing on Tracefour is dated Aug 10, 2026.
What is Keyes Jason A's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Keyes Jason A is listed as Chief Financial Officer.
What is Keyes Jason A's total buy and sell value in the current window?
Inside the rolling retention window, Keyes Jason A bought $11K and sold $0 based on SEC Form 4 filings.
What was Keyes Jason A's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 700 BLSM shares on 2026-08-10, worth $11K, per SEC Form 4 filings.